title: Invasive aspergillosis in the setting of cardiac transplantation.
abstract: Among patients undergoing heart transplantation, Aspergillus is the opportunistic pathogen with the highest attributable mortality. The median time of onset from transplantation for invasive pulmonary aspergillosis (IPA) was 46 days, but the median time to first positive culture result was 104 days among patients with Aspergillus colonization but no invasive disease. Most patients with IPA presented with fever and cough within the first 90 days of transplantation and with single or multiple pulmonary nodules. None of the heart transplant recipients with either IPA or invasive extrapulmonary aspergillosis (IEPA) had associated neutropenia. Human leukocyte antigen A1 locus was found significantly more frequently among patients colonized with Aspergillus than among patients with IPA (P<.006) or IEPA (P<.001). Even in the absence of neutropenia, IPA should be suspected for heart transplant recipients who have fever and respiratory symptoms within the first 3 months of transplantation, have a positive result of culture of respiratory secretions, and have abnormal radiological findings (particularly nodules).
authors.affiliation: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305-5107, USA. gilberto@leland.stanford.edu
authors.forename: J G
authors.initials: JG
authors.lastname: Montoya
authors.forename: S V
authors.initials: SV
authors.lastname: Chaparro
authors.forename: D
authors.initials: D
authors.lastname: Celis
authors.forename: J A
authors.initials: JA
authors.lastname: Cortés
authors.forename: A N
authors.initials: AN
authors.lastname: Leung
authors.forename: R C
authors.initials: RC
authors.lastname: Robbins
authors.forename: D A
authors.initials: DA
authors.lastname: Stevens
mesh_terms: D000328:Adult; D001228:Aspergillosis / Q000453:epidemiology* / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control; D001232:Aspergillus fumigatus; D018890:Chemoprevention; D005260:Female; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology* / Q000401:mortality / Q000503:physiopathology / Q000517:prevention & control; D012307:Risk Factors